How to validate CCIT with a sensitivity of 0.01µm

USP1207, chapter 6 focusses on inherent package integrity, putting the emphasis on a robust Container Closure Integrity (CCI) strategy.

 

While some methods struggle to reach the sensitivities required for validation of the integrity of a newly designed or modified container, the combination of Headspace Analysis (HSA) and Bombing offers a precise, non-destructive path to achieve a Limit of Detection down to 0.01 µm, - way below the Maximum Allowable Leakage Limit (MALL) mentioned in USP1207.

Understanding Inherent CCIT (ICCIT)

Before a drug product ever reaches a commercial filling line, manufacturers must prove that the chosen packaging is "integrity-positive" by design. This is known as inherent CCIT.

 

ICCIT is a foundational validation of the package's architecture. It confirms that the specific combination of components, such as a specific glass vial, elastomer stopper, and aluminium seal, possesses the intrinsic capability to act as a total barrier. When assembled to specification, this system must prevent the ingress of microorganisms or moisture and the escape of nitrogen. By establishing the ICCIT, you demonstrate that your container-closure system can maintain the sterile barrier, provided it remains below the Maximum Allowable Leakage Limit (MALL).

Establishing the Maximum Allowable Leakage Limit

Central to any CCIT strategy is the Maximum Allowable Leakage Limit (MALL). The MALL is the highest leakage rate (or leak size) that a specific drug product can tolerate without compromising its safety, identity, strength, or purity. The MALL is not a universal constant; it is a product-specific value that accounts for the sensitivity of the active ingredient and the environmental risks. For liquid sterile products, USP MALL is typically used. Since gas species can readily penetrate defects <0.1 µm, more stringent MALL may be required if headspace content conservation is needed, e.g. to prevent oxygen ingress. Validating a system to 0.01 µm provides a critical safety buffer, ensuring that even the most minute integrity risks are accounted for.

The Methodology: Headspace Analysis and Bombing

To achieve ultra-high sensitivity, a two-step process is utilized:

  1. Bombing: The closed, finished containers are placed in a pressure chamber filled with a tracer gas (typically CO2). Under high pressure, if a microscopic leak exists, the tracer gas is forced into the headspace of the container at an accelerated rate.
  2. Headspace Analysis (HSA): After the bombing cycle, a laser-based analyzer (like the NEO HSX) measures the concentration of the tracer gas inside the container. Because the method is non-destructive, the same samples can be used for further studies.

 

Why Choose HSA + Bombing?

This approach offers several strategic advantages for the lab. It reaches sensitivities down to 0.01 µm. This is critical for high-risk products where the MALL is set at a very stringent level. Unlike some methods that only test certain sections of the container, this validates the fully finished and closed container, accounting for glass defects, stopper porosity, and capping quality simultaneously.

 

Compared to Helium (He) leak testing, CO2 permeation through elastomers is significantly slower. This provides a more stable measurement window and reduces the risk of "false rejects" due to gas escaping before the test is completed. It is easier to handle, and it is non-destructive thus can be used as a test procedure during production.

 

The HSA technology is versatile. The same equipment used for ultra-sensitive validation can be used for routine oxygen monitoring or moisture analysis in stability studies.

A Fast Track to Annex 1 Compliance

The combination of Bombing plus HSA is a "fast track" for manufacturers looking to align with Annex 1 and USP 1207 expectations. It provides the empirical data needed for a robust Container Closure Integrity Testing (CCIT) during the development stage and is an invaluable tool for supplier qualification.

 

The NEO HSX + Bombing Station is specifically designed for this purpose. It allows labs to perform high-level ICCIT studies in-house, ensuring that when you scale to production, your packaging system has already been proven at the highest possible standard.

Contact us for more information

Open Form Popup

You want flexible CCI tests in your laboratory?

We are happy to advise you personally

Open Form Popup